This article is more than 5 years old. Information may no longer be current.

Top stories in cardiology: Technology with smartphone camera may measure BP, FDA designates recall of implantable cardioverter defibrillator as class 1

Among the top stories in cardiology last week were a study that found the use of a novel smartphone-based technology to measure blood pressure fell within 5 mm Hg of reference measurements in adults who were normotensive and the FDA designating Abbott’s product recall of an implantable cardioverter defibrillator as a class 1 recall.

Other highlights included a commentary that assessed the role of dulaglutide for the primary prevention of CVD, a study that determined eating more plant-based foods and less animal products lowered the risk for CV morbidity and mortality in a general population of middle-aged adults and data that suggested patients with atherosclerotic cardiovascular disease who received care by a cardiologist had higher rates of guideline-based statin use and adherence in an outpatient setting.

Novel technology with smartphone camera may measure blood pressure

The use of a novel smartphone-based technology — transdermal optical imaging — to measure blood pressure fell within 5 mm Hg of reference measurements in adults who were normotensive, according to a study published in Circulation: Cardiovascular Imaging. Read more.

FDA designates recall of implantable cardioverter defibrillator as class 1

The FDA has designated Abbott’s product recall of an implantable cardioverter defibrillator as a class 1 recall, the most serious kind. The recall affects 108 devices manufactured and distributed between April 5 and June 14. Read more.

REWIND: Assessing the role of dulaglutide for primary prevention of CVD

Within the past decade, there has been a rapid development of novel antihyperglycemic agents that not only improve glycemic control but also reduce CV events in patients with known atherosclerotic CVD. Two major drug classes have been associated with a reduction in major adverse cardiac events: the SGLT2 inhibitors and the GLP-1 receptor agonists. Read more.

Healthy plant-based diet lowers risk for CVD mortality, morbidity

Eating more plant-based foods and less animal products lowered the risk for CV morbidity and mortality in a general population of middle-aged adults. Read more.

Guideline-based statin use, adherence higher with cardiologist care

Patients with atherosclerotic cardiovascular disease who receive care by a cardiologist had higher rates of guideline-based statin use and adherence in an outpatient setting, according to data published in the American Journal of Cardiology. Read more.